| Cancer-type | Pathway | Q-value | P-value | Pathway size | Cancer set size | DP | DN | GP | GN |
| Ley_leukemia | hsa05221:Acute myeloid leukemia | 1 | 0.0207 | 57 | 1 | 1 | 0 | 57 | 2738 |
| Ley_leukemia | hsa04640:Hematopoietic cell lineage | 1 | 0.0297 | 82 | 1 | 1 | 0 | 82 | 2713 |
| Ley_leukemia | hsa04060:Cytokine-cytokine receptor interaction | 1 | 0.0776 | 216 | 1 | 1 | 0 | 216 | 2579 |
| Ley_leukemia | hsa00010:Glycolysis / Gluconeogenesis | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa00020:Citrate cycle (TCA cycle) | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa00030:Pentose phosphate pathway | 1 | 1 | 19 | 1 | 0 | 1 | 19 | 2776 |
| Ley_leukemia | hsa00051:Fructose and mannose metabolism | 1 | 1 | 22 | 1 | 0 | 1 | 22 | 2773 |
| Ley_leukemia | hsa00052:Galactose metabolism | 1 | 1 | 17 | 1 | 0 | 1 | 17 | 2778 |
| Ley_leukemia | hsa00071:Fatty acid metabolism | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa00100:Biosynthesis of steroids | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00120:Bile acid biosynthesis | 1 | 1 | 10 | 1 | 0 | 1 | 10 | 2785 |
| Ley_leukemia | hsa00150:Androgen and estrogen metabolism | 1 | 1 | 14 | 1 | 0 | 1 | 14 | 2781 |
| Ley_leukemia | hsa00190:Oxidative phosphorylation | 1 | 1 | 56 | 1 | 0 | 1 | 56 | 2739 |
| Ley_leukemia | hsa00220:Urea cycle and metabolism of amino groups | 1 | 1 | 14 | 1 | 0 | 1 | 14 | 2781 |
| Ley_leukemia | hsa00230:Purine metabolism | 1 | 1 | 87 | 1 | 0 | 1 | 87 | 2708 |
| Ley_leukemia | hsa00240:Pyrimidine metabolism | 1 | 1 | 53 | 1 | 0 | 1 | 53 | 2742 |
| Ley_leukemia | hsa00251:Glutamate metabolism | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa00252:Alanine and aspartate metabolism | 1 | 1 | 19 | 1 | 0 | 1 | 19 | 2776 |
| Ley_leukemia | hsa00260:Glycine, serine and threonine metabolism | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa00280:Valine, leucine and isoleucine degradation | 1 | 1 | 14 | 1 | 0 | 1 | 14 | 2781 |
| Ley_leukemia | hsa00310:Lysine degradation | 1 | 1 | 25 | 1 | 0 | 1 | 25 | 2770 |
| Ley_leukemia | hsa00330:Arginine and proline metabolism | 1 | 1 | 23 | 1 | 0 | 1 | 23 | 2772 |
| Ley_leukemia | hsa00340:Histidine metabolism | 1 | 1 | 16 | 1 | 0 | 1 | 16 | 2779 |
| Ley_leukemia | hsa00350:Tyrosine metabolism | 1 | 1 | 25 | 1 | 0 | 1 | 25 | 2770 |
| Ley_leukemia | hsa00360:Phenylalanine metabolism | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00361:gamma-Hexachlorocyclohexane degradation | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00380:Tryptophan metabolism | 1 | 1 | 30 | 1 | 0 | 1 | 30 | 2765 |
| Ley_leukemia | hsa00410:beta-Alanine metabolism | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00440:Aminophosphonate metabolism | 1 | 1 | 10 | 1 | 0 | 1 | 10 | 2785 |
| Ley_leukemia | hsa00450:Selenoamino acid metabolism | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00480:Glutathione metabolism | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa00500:Starch and sucrose metabolism | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa00510:N-Glycan biosynthesis | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa00511:N-Glycan degradation | 1 | 1 | 10 | 1 | 0 | 1 | 10 | 2785 |
| Ley_leukemia | hsa00512:O-Glycan biosynthesis | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00530:Aminosugars metabolism | 1 | 1 | 14 | 1 | 0 | 1 | 14 | 2781 |
| Ley_leukemia | hsa00561:Glycerolipid metabolism | 1 | 1 | 19 | 1 | 0 | 1 | 19 | 2776 |
| Ley_leukemia | hsa00562:Inositol phosphate metabolism | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa00564:Glycerophospholipid metabolism | 1 | 1 | 36 | 1 | 0 | 1 | 36 | 2759 |
| Ley_leukemia | hsa00565:Ether lipid metabolism | 1 | 1 | 16 | 1 | 0 | 1 | 16 | 2779 |
| Ley_leukemia | hsa00590:Arachidonic acid metabolism | 1 | 1 | 26 | 1 | 0 | 1 | 26 | 2769 |
| Ley_leukemia | hsa00591:Linoleic acid metabolism | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00600:Sphingolipid metabolism | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa00620:Pyruvate metabolism | 1 | 1 | 21 | 1 | 0 | 1 | 21 | 2774 |
| Ley_leukemia | hsa00626:Naphthalene and anthracene degradation | 1 | 1 | 10 | 1 | 0 | 1 | 10 | 2785 |
| Ley_leukemia | hsa00632:Benzoate degradation via CoA ligation | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00640:Propanoate metabolism | 1 | 1 | 15 | 1 | 0 | 1 | 15 | 2780 |
| Ley_leukemia | hsa00650:Butanoate metabolism | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa00710:Carbon fixation | 1 | 1 | 16 | 1 | 0 | 1 | 16 | 2779 |
| Ley_leukemia | hsa00740:Riboflavin metabolism | 1 | 1 | 11 | 1 | 0 | 1 | 11 | 2784 |
| Ley_leukemia | hsa00790:Folate biosynthesis | 1 | 1 | 25 | 1 | 0 | 1 | 25 | 2770 |
| Ley_leukemia | hsa00860:Porphyrin and chlorophyll metabolism | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00903:Limonene and pinene degradation | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00910:Nitrogen metabolism | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa00930:Caprolactam degradation | 1 | 1 | 10 | 1 | 0 | 1 | 10 | 2785 |
| Ley_leukemia | hsa00970:Aminoacyl-tRNA biosynthesis | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa00980:Metabolism of xenobiotics by cytochrome P450 | 1 | 1 | 17 | 1 | 0 | 1 | 17 | 2778 |
| Ley_leukemia | hsa01030:Glycan structures - biosynthesis 1 | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa01031:Glycan structures - biosynthesis 2 | 1 | 1 | 19 | 1 | 0 | 1 | 19 | 2776 |
| Ley_leukemia | hsa01032:Glycan structures - degradation | 1 | 1 | 16 | 1 | 0 | 1 | 16 | 2779 |
| Ley_leukemia | hsa01430:Cell Communication | 1 | 1 | 84 | 1 | 0 | 1 | 84 | 2711 |
| Ley_leukemia | hsa01510:Neurodegenerative Diseases | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa02010:ABC transporters - General | 1 | 1 | 21 | 1 | 0 | 1 | 21 | 2774 |
| Ley_leukemia | hsa03010:Ribosome | 1 | 1 | 43 | 1 | 0 | 1 | 43 | 2752 |
| Ley_leukemia | hsa03020:RNA polymerase | 1 | 1 | 15 | 1 | 0 | 1 | 15 | 2780 |
| Ley_leukemia | hsa03022:Basal transcription factors | 1 | 1 | 28 | 1 | 0 | 1 | 28 | 2767 |
| Ley_leukemia | hsa03030:DNA polymerase | 1 | 1 | 21 | 1 | 0 | 1 | 21 | 2774 |
| Ley_leukemia | hsa03050:Proteasome | 1 | 1 | 21 | 1 | 0 | 1 | 21 | 2774 |
| Ley_leukemia | hsa03320:PPAR signaling pathway | 1 | 1 | 38 | 1 | 0 | 1 | 38 | 2757 |
| Ley_leukemia | hsa04010:MAPK signaling pathway | 1 | 1 | 225 | 1 | 0 | 1 | 225 | 2570 |
| Ley_leukemia | hsa04012:ErbB signaling pathway | 1 | 1 | 86 | 1 | 0 | 1 | 86 | 2709 |
| Ley_leukemia | hsa04020:Calcium signaling pathway | 1 | 1 | 151 | 1 | 0 | 1 | 151 | 2644 |
| Ley_leukemia | hsa04070:Phosphatidylinositol signaling system | 1 | 1 | 55 | 1 | 0 | 1 | 55 | 2740 |
| Ley_leukemia | hsa04080:Neuroactive ligand-receptor interaction | 1 | 1 | 198 | 1 | 0 | 1 | 198 | 2597 |
| Ley_leukemia | hsa04110:Cell cycle | 1 | 1 | 106 | 1 | 0 | 1 | 106 | 2689 |
| Ley_leukemia | hsa04115:p53 signaling pathway | 1 | 1 | 59 | 1 | 0 | 1 | 59 | 2736 |
| Ley_leukemia | hsa04120:Ubiquitin mediated proteolysis | 1 | 1 | 105 | 1 | 0 | 1 | 105 | 2690 |
| Ley_leukemia | hsa04130:SNARE interactions in vesicular transport | 1 | 1 | 28 | 1 | 0 | 1 | 28 | 2767 |
| Ley_leukemia | hsa04140:Regulation of autophagy | 1 | 1 | 17 | 1 | 0 | 1 | 17 | 2778 |
| Ley_leukemia | hsa04150:mTOR signaling pathway | 1 | 1 | 48 | 1 | 0 | 1 | 48 | 2747 |
| Ley_leukemia | hsa04210:Apoptosis | 1 | 1 | 81 | 1 | 0 | 1 | 81 | 2714 |
| Ley_leukemia | hsa04310:Wnt signaling pathway | 1 | 1 | 123 | 1 | 0 | 1 | 123 | 2672 |
| Ley_leukemia | hsa04320:Dorso-ventral axis formation | 1 | 1 | 22 | 1 | 0 | 1 | 22 | 2773 |
| Ley_leukemia | hsa04330:Notch signaling pathway | 1 | 1 | 40 | 1 | 0 | 1 | 40 | 2755 |
| Ley_leukemia | hsa04340:Hedgehog signaling pathway | 1 | 1 | 43 | 1 | 0 | 1 | 43 | 2752 |
| Ley_leukemia | hsa04350:TGF-beta signaling pathway | 1 | 1 | 82 | 1 | 0 | 1 | 82 | 2713 |
| Ley_leukemia | hsa04360:Axon guidance | 1 | 1 | 111 | 1 | 0 | 1 | 111 | 2684 |
| Ley_leukemia | hsa04370:VEGF signaling pathway | 1 | 1 | 63 | 1 | 0 | 1 | 63 | 2732 |
| Ley_leukemia | hsa04510:Focal adhesion | 1 | 1 | 181 | 1 | 0 | 1 | 181 | 2614 |
| Ley_leukemia | hsa04512:ECM-receptor interaction | 1 | 1 | 73 | 1 | 0 | 1 | 73 | 2722 |
| Ley_leukemia | hsa04514:Cell adhesion molecules (CAMs) | 1 | 1 | 109 | 1 | 0 | 1 | 109 | 2686 |
| Ley_leukemia | hsa04520:Adherens junction | 1 | 1 | 71 | 1 | 0 | 1 | 71 | 2724 |
| Ley_leukemia | hsa04530:Tight junction | 1 | 1 | 106 | 1 | 0 | 1 | 106 | 2689 |
| Ley_leukemia | hsa04540:Gap junction | 1 | 1 | 79 | 1 | 0 | 1 | 79 | 2716 |
| Ley_leukemia | hsa04610:Complement and coagulation cascades | 1 | 1 | 67 | 1 | 0 | 1 | 67 | 2728 |
| Ley_leukemia | hsa04612:Antigen processing and presentation | 1 | 1 | 70 | 1 | 0 | 1 | 70 | 2725 |
| Ley_leukemia | hsa04614:Renin-angiotensin system | 1 | 1 | 16 | 1 | 0 | 1 | 16 | 2779 |
| Ley_leukemia | hsa04620:Toll-like receptor signaling pathway | 1 | 1 | 89 | 1 | 0 | 1 | 89 | 2706 |
| Ley_leukemia | hsa04630:Jak-STAT signaling pathway | 1 | 1 | 132 | 1 | 0 | 1 | 132 | 2663 |
| Ley_leukemia | hsa04650:Natural killer cell mediated cytotoxicity | 1 | 1 | 117 | 1 | 0 | 1 | 117 | 2678 |
| Ley_leukemia | hsa04660:T cell receptor signaling pathway | 1 | 1 | 89 | 1 | 0 | 1 | 89 | 2706 |
| Ley_leukemia | hsa04662:B cell receptor signaling pathway | 1 | 1 | 61 | 1 | 0 | 1 | 61 | 2734 |
| Ley_leukemia | hsa04664:Fc epsilon RI signaling pathway | 1 | 1 | 67 | 1 | 0 | 1 | 67 | 2728 |
| Ley_leukemia | hsa04670:Leukocyte transendothelial migration | 1 | 1 | 99 | 1 | 0 | 1 | 99 | 2696 |
| Ley_leukemia | hsa04710:Circadian rhythm | 1 | 1 | 12 | 1 | 0 | 1 | 12 | 2783 |
| Ley_leukemia | hsa04720:Long-term potentiation | 1 | 1 | 63 | 1 | 0 | 1 | 63 | 2732 |
| Ley_leukemia | hsa04730:Long-term depression | 1 | 1 | 68 | 1 | 0 | 1 | 68 | 2727 |
| Ley_leukemia | hsa04740:Olfactory transduction | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa04742:Taste transduction | 1 | 1 | 22 | 1 | 0 | 1 | 22 | 2773 |
| Ley_leukemia | hsa04810:Regulation of actin cytoskeleton | 1 | 1 | 184 | 1 | 0 | 1 | 184 | 2611 |
| Ley_leukemia | hsa04910:Insulin signaling pathway | 1 | 1 | 123 | 1 | 0 | 1 | 123 | 2672 |
| Ley_leukemia | hsa04912:GnRH signaling pathway | 1 | 1 | 82 | 1 | 0 | 1 | 82 | 2713 |
| Ley_leukemia | hsa04916:Melanogenesis | 1 | 1 | 80 | 1 | 0 | 1 | 80 | 2715 |
| Ley_leukemia | hsa04920:Adipocytokine signaling pathway | 1 | 1 | 62 | 1 | 0 | 1 | 62 | 2733 |
| Ley_leukemia | hsa04930:Type II diabetes mellitus | 1 | 1 | 43 | 1 | 0 | 1 | 43 | 2752 |
| Ley_leukemia | hsa04940:Type I diabetes mellitus | 1 | 1 | 43 | 1 | 0 | 1 | 43 | 2752 |
| Ley_leukemia | hsa04950:Maturity onset diabetes of the young | 1 | 1 | 18 | 1 | 0 | 1 | 18 | 2777 |
| Ley_leukemia | hsa05010:Alzheimer's disease | 1 | 1 | 28 | 1 | 0 | 1 | 28 | 2767 |
| Ley_leukemia | hsa05020:Parkinson's disease | 1 | 1 | 20 | 1 | 0 | 1 | 20 | 2775 |
| Ley_leukemia | hsa05030:Amyotrophic lateral sclerosis (ALS) | 1 | 1 | 19 | 1 | 0 | 1 | 19 | 2776 |
| Ley_leukemia | hsa05040:Huntington's disease | 1 | 1 | 28 | 1 | 0 | 1 | 28 | 2767 |
| Ley_leukemia | hsa05050:Dentatorubropallidoluysian atrophy (DRPLA) | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa05060:Prion disease | 1 | 1 | 13 | 1 | 0 | 1 | 13 | 2782 |
| Ley_leukemia | hsa05110:Cholera - Infection | 1 | 1 | 29 | 1 | 0 | 1 | 29 | 2766 |
| Ley_leukemia | hsa05120:Epithelial cell signaling in Helicobacter pylori infection | 1 | 1 | 54 | 1 | 0 | 1 | 54 | 2741 |
| Ley_leukemia | hsa05130:Pathogenic Escherichia coli infection - EHEC | 1 | 1 | 40 | 1 | 0 | 1 | 40 | 2755 |
| Ley_leukemia | hsa05131:Pathogenic Escherichia coli infection - EPEC | 1 | 1 | 40 | 1 | 0 | 1 | 40 | 2755 |
| Ley_leukemia | hsa05210:Colorectal cancer | 1 | 1 | 84 | 1 | 0 | 1 | 84 | 2711 |
| Ley_leukemia | hsa05211:Renal cell carcinoma | 1 | 1 | 66 | 1 | 0 | 1 | 66 | 2729 |
| Ley_leukemia | hsa05212:Pancreatic cancer | 1 | 1 | 75 | 1 | 0 | 1 | 75 | 2720 |
| Ley_leukemia | hsa05213:Endometrial cancer | 1 | 1 | 51 | 1 | 0 | 1 | 51 | 2744 |
| Ley_leukemia | hsa05214:Glioma | 1 | 1 | 61 | 1 | 0 | 1 | 61 | 2734 |
| Ley_leukemia | hsa05215:Prostate cancer | 1 | 1 | 84 | 1 | 0 | 1 | 84 | 2711 |
| Ley_leukemia | hsa05216:Thyroid cancer | 1 | 1 | 29 | 1 | 0 | 1 | 29 | 2766 |
| Ley_leukemia | hsa05217:Basal cell carcinoma | 1 | 1 | 43 | 1 | 0 | 1 | 43 | 2752 |
| Ley_leukemia | hsa05218:Melanoma | 1 | 1 | 64 | 1 | 0 | 1 | 64 | 2731 |
| Ley_leukemia | hsa05219:Bladder cancer | 1 | 1 | 42 | 1 | 0 | 1 | 42 | 2753 |
| Ley_leukemia | hsa05220:Chronic myeloid leukemia | 1 | 1 | 76 | 1 | 0 | 1 | 76 | 2719 |
| Ley_leukemia | hsa05222:Small cell lung cancer | 1 | 1 | 85 | 1 | 0 | 1 | 85 | 2710 |
| Ley_leukemia | hsa05223:Non-small cell lung cancer | 1 | 1 | 55 | 1 | 0 | 1 | 55 | 2740 |